Aphp Hopital Saint Antoine

Paris 75571

1 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Hepatocellular Carcinoma, Non Alcoholic Steatohepatitis (NASH)

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling
• Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis — Status unconfirmed